Tesamorelin

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog developed to reduce excess abdominal fat in individuals with HIV-associated lipodystrophy. By stimulating the natural production of human growth hormone, it targets visceral adipose tissue around the stomach. While offering promising benefits, it’s essential to consider possible side effects and the need for further research to comprehensively understand its long-term impact.

This peptide comes in lyophilized vials.